Cary, NC, United States of America

Ronald George Sherrill

This inventor holds 11 USPTO granted patents and 3 published patent applications. Top assignees: Vertex Pharmaceuticals, Inc., Glaxo Wellcome Inc., Shionogi Company Limited. Active years: 1998-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald George Sherrill. Retrieved from https://idiyas.com/inventor/ronald-george-sherrill

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 54.5

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 73(Granted Patents)


Location History:

  • Cary, NC (US) (1998 - 2013)
  • Durham, NC (US) (2008 - 2014)

Company Filing History:


Years Active: 1998-2014

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Ronald George Sherrill: Innovator in HIV Research

Introduction

Ronald George Sherrill is a prominent inventor based in Cary, North Carolina. With a remarkable portfolio of 11 patents, his work focuses primarily on the development of innovative compounds aimed at combating HIV. His contributions are significant in the fields of pharmaceutical science and infectious disease.

Latest Patents

Among his latest patents is the invention of 2-oxonaphthyridine-3-carboxamides, which serve as HIV integrase inhibitors. This invention provides compounds that inhibit HIV replication and offers potential treatments for HIV and AIDS. Another notable patent includes inhibitors of aspartyl protease, a novel class of sulfonamides that effectively inhibit HIV-1 and HIV-2 protease activity. The pharmaceutical compositions derived from this invention are tailored for use as antiviral agents, showcasing their utility against these significant viruses.

Career Highlights

Throughout his career, Ronald has worked with several distinguished pharmaceutical companies, including Vertex Pharmaceuticals, Inc. and Glaxo Wellcome Inc. His tenure at these organizations allowed him to collaborate on groundbreaking research that has had a profound impact on HIV treatment options.

Collaborations

Ronald's innovative journey has seen him partner with esteemed colleagues such as Michael Robin Hale and Andrew Spaltenstein. These collaborations have facilitated the blending of expertise crucial for driving forward the development of effective therapeutic agents against HIV.

Conclusion

In conclusion, Ronald George Sherrill stands out as a key inventor in the fight against HIV. His patents reflect a commitment to enhancing medical treatments and improving lives through innovation. His work exemplifies the vital role of inventors in addressing critical public health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…